Trinity College Dublin

Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors

Retrieved on: 
Thursday, March 28, 2024

Gallagher is the sixth director to join our board of directors in the past twelve months as we continue to refresh and strengthen the Board governance and oversight required for the next stage of the Company’s development and growth,” said Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks.

Key Points: 
  • Gallagher is the sixth director to join our board of directors in the past twelve months as we continue to refresh and strengthen the Board governance and oversight required for the next stage of the Company’s development and growth,” said Kenneth Galbraith, Chair and Chief Executive Officer of Zymeworks.
  • Dr. Gallagher has directly led or overseen multiple medical product approvals globally, including biologics and small molecules, across several therapeutic areas.
  • Before joining Syndax Pharmaceuticals in 2023, Dr. Gallagher was Head of Development and Chief Medical Officer of AbbVie.
  • Dr. Gallagher was also appointed to serve as a member of the research and development committee of the board of directors.

Zeevo Group’s Client Success Team Gets Boost With New Member Megan King

Retrieved on: 
Tuesday, April 9, 2024

Zeevo Group LLC ("Zeevo"), an operations, finance, and information technology consulting services firm, welcomed Megan King as a new member of its Client Success Team.

Key Points: 
  • Zeevo Group LLC ("Zeevo"), an operations, finance, and information technology consulting services firm, welcomed Megan King as a new member of its Client Success Team.
  • "With her extensive network of relationships with aircraft leasing companies, airlines, manufacturers, and maintenance service providers, she is the perfect fit for our Client Success Team."
  • King joins Zeevo from Smithbucklin following a ten-year-plus tenure at the association management company that delivers management and specialized services to trade and professional associations.
  • "I am thrilled and honored to be joining the elite team at Zeevo," said Megan King, a newly appointed consultant of Zeevo Group.

OncoOne Announces Formation of Clinical Advisory Board to Support Development of ON104 for Chronic Inflammatory Diseases

Retrieved on: 
Tuesday, March 12, 2024

OncoOne , a biotechnology company focused on discovering precision medicines for cancer and autoimmune diseases, announced today the formation of a clinical advisory board to provide strategic and clinical insights for the company’s lead program in immunology, ON104.

Key Points: 
  • OncoOne , a biotechnology company focused on discovering precision medicines for cancer and autoimmune diseases, announced today the formation of a clinical advisory board to provide strategic and clinical insights for the company’s lead program in immunology, ON104.
  • ON104 is a monoclonal antibody targeting the oxidized isoform of the macrophage migration inhibitory factor (oxMIF) for the treatment of chronic inflammatory diseases.
  • His research focuses on arthritis and other inflammatory rheumatic diseases, precision medicine, and the management of complex diseases.
  • Dr. Freissmuth is an inaugural member of OncoOne’s scientific advisory board, where he continues to support the development of the company’s pipeline of biotherapeutics.

Health and social care veteran regulator Ginny Hanrahan joins Thentia's growing team of regulatory subject matter experts

Retrieved on: 
Friday, March 15, 2024

Thentia announces the addition of veteran health and social care regulator Ginny Hanrahan to its regulatory SME team.

Key Points: 
  • Thentia announces the addition of veteran health and social care regulator Ginny Hanrahan to its regulatory SME team.
  • DUBLIN, March 15, 2024 /PRNewswire/ - As part of its ongoing commitment to regulatory excellence, Thentia is pleased to welcome Ginny Hanrahan to its global team of regulatory experts.
  • With a career in health and social care spanning four decades, including 15 spent as the inaugural CEO and Registrar at CORU, Ireland's multi-profession health and social care regulator, Ms. Hanrahan joins Thentia as an independent consultant and will use her considerable regulatory expertise to support the company's growing European business.
  • "We are delighted to welcome Ginny to our regulatory team," says Julian Cardarelli, Chief Executive Officer, Thentia.

Health and social care veteran regulator Ginny Hanrahan joins Thentia's growing team of regulatory subject matter experts

Retrieved on: 
Friday, March 15, 2024

DUBLIN, March 15, 2024 /PRNewswire/ -- As part of its ongoing commitment to regulatory excellence, Thentia is pleased to welcome Ginny Hanrahan to its global team of regulatory experts. With a career in health and social care spanning four decades, including 15 spent as the inaugural CEO and Registrar at CORU, Ireland's multi-profession health and social care regulator, Ms. Hanrahan joins Thentia as an independent consultant and will use her considerable regulatory expertise to support the company's growing European business.

Key Points: 
  • Thentia announces the addition of veteran health and social care regulator Ginny Hanrahan to its regulatory SME team.
  • DUBLIN, March 15, 2024 /PRNewswire/ -- As part of its ongoing commitment to regulatory excellence, Thentia is pleased to welcome Ginny Hanrahan to its global team of regulatory experts.
  • With a career in health and social care spanning four decades, including 15 spent as the inaugural CEO and Registrar at CORU, Ireland's multi-profession health and social care regulator, Ms. Hanrahan joins Thentia as an independent consultant and will use her considerable regulatory expertise to support the company's growing European business.
  • "We are delighted to welcome Ginny to our regulatory team," says Julian Cardarelli, Chief Executive Officer, Thentia.

Shocked to the core: a new model to understand euro area inflation

Retrieved on: 
Tuesday, April 2, 2024

The pandemic's disruption of global supply chains and the spike in natural gas prices following Russia’s invasion of Ukraine were significant drivers of surging inflation.

Key Points: 
  • The pandemic's disruption of global supply chains and the spike in natural gas prices following Russia’s invasion of Ukraine were significant drivers of surging inflation.
  • Traditional inflation models often ignore such supply-side shocks, even though they can have a significant and persistent impact on core inflation in the euro area (as measured by rates of change in the Harmonised Index of Consumer Prices excluding the energy and food components).

Generative AI adoption rates on the rise in workplaces according to new Microsoft Ireland and Trinity College Dublin report

Retrieved on: 
Thursday, February 29, 2024

DUBLIN, Feb. 29, 2024 /PRNewswire/ -- Microsoft Ireland has today unveiled a new AI report, Generative AI in Ireland 2024, which reveals that almost half of organisations across public and private sectors have started to adopt Generative AI. Ireland's position as a global technology hub is a significant driver of adoption rates, with multinationals claiming to use 30% more generative AI than indigenous organisations.

Key Points: 
  • Those with a generative AI-first policy (company-wide approach) feel there are more benefits, such as productivity increases, from generative AI (71%) compared to firms that prohibit generative AI use.
  • DUBLIN, Feb. 29, 2024 /PRNewswire/ -- Microsoft Ireland has today unveiled a new AI report, Generative AI in Ireland 2024, which reveals that almost half of organisations across public and private sectors have started to adopt Generative AI.
  • Ireland's position as a global technology hub is a significant driver of adoption rates, with multinationals claiming to use 30% more generative AI than indigenous organisations.
  • Today's publication points to rising adoption rates of generative AI solutions within Irish workplaces – with 49% highlighting generative AI being used in some form within their organisation.

First Published Articles of APL Quantum Now Live

Retrieved on: 
Wednesday, February 28, 2024

MELVILLE, N.Y., Feb. 28, 2024 /PRNewswire/ -- AIP Publishing is thrilled to announce the first published articles of APL Quantum , its latest open access journal.

Key Points: 
  • MELVILLE, N.Y., Feb. 28, 2024 /PRNewswire/ -- AIP Publishing is thrilled to announce the first published articles of APL Quantum , its latest open access journal.
  • APL Quantum publishes the latest and most innovative research across all of quantum science, including but not limited to fundamentals, phenomena, resources, applied science, and technologies.
  • APL Quantum's first articles serve as a strong example of the new journal's impressive scope, featuring articles on quantum materials, the modeling of quantum fluctuations and establishment and use of quantum technologies, and the conception of a programmable photonic quantum emulator.
  • "The first issue of APL Quantum is an exciting and pivotal moment for AIP Publishing and the broader research community," said Dr. Penelope Lewis, AIP Publishing's Chief Publishing Officer.

Cairn Homes Plc: Appointment of Chief Financial Officer

Retrieved on: 
Tuesday, February 13, 2024

Richard Ball, an experienced real estate professional, will join Cairn as Chief Financial Officer

Key Points: 
  • Richard Ball, an experienced real estate professional, will join Cairn as Chief Financial Officer
    Dublin/London, 13 February 2024: Cairn Homes plc (“Cairn” or “the Company”) (Euronext Dublin: C5H / LSE: CRN), a leading Irish homebuilding company, today announces, following a comprehensive recruitment process, the appointment of Richard Ball as Chief Financial Officer (“CFO”), succeeding Shane Doherty.
  • Prior to that, he served as Chief Investment Officer at Hibernia REIT plc, an Irish commercial real estate company, for a period of five years from its IPO.
  • John Reynolds, Chairman of Cairn, said: "We are delighted to be appointing a high calibre candidate in Richard Ball as CFO.
  • A new Cairn home is expertly designed, with a focus on creating shared spaces and environments where communities thrive.